Virbac (Australia) Pty Limited
Exhibitor
Virbac is the largest independent company worldwide exclusively dedicated to animal health and proud to support the Australian veterinary profession and pet owners.
In 2021, Virbac launched STELFONTA, a breakthrough injectable non-surgical solution for mast cell tumours (MCTs) in dogs. STELFONTA is a targeted intratumoural treatment and a single treatment destroys the mast cell tumour completely in 75% of observed cases and 87% of tumours with up to two treatments. STELFONTA® contains tigilanol tiglate, a biologically active pharmaceutical compound extracted from the seed of the native Australian blushwood (Fontainea picrosperma) tree.
In 2021, Virbac launched STELFONTA, a breakthrough injectable non-surgical solution for mast cell tumours (MCTs) in dogs. STELFONTA is a targeted intratumoural treatment and a single treatment destroys the mast cell tumour completely in 75% of observed cases and 87% of tumours with up to two treatments. STELFONTA® contains tigilanol tiglate, a biologically active pharmaceutical compound extracted from the seed of the native Australian blushwood (Fontainea picrosperma) tree.
Contact us
Sponsorship Enquiries
Regina.Portelli@terrapinn.com
Speaking Enquiries
Marketing Enquiries
General Enquiries
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events